A Comparative Double Blind Trial of Pimozide and Fluphenazine in Chronic Schizophrenia

Patricia A. Morris, D. H. MacKenzie, H. C. Masheter

The British Journal of Psychiatry · 1970 · 29 citations · 0 references

Concepts

Abstract

Pimozide is a new neuroleptic drug and is chemically described as bis-para-fluoro-phenyl-butylpiperidine. It is active after oral administration, with a 24 hour duration of action and a peak effect lasting four to six hours (1). Superiority over placebo has been demonstrated by Brugmans (2).